NYSE:HCA - HCA Healthcare Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $240.44
  • Forecasted Upside: -3.23 %
  • Number of Analysts: 19
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 17 Buy Ratings
  • 0 Strong Buy Ratings
▲ +1.67 (0.68%)

This chart shows the closing price for HCA by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New HCA Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HCA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HCA

Analyst Price Target is $240.44
▼ -3.23% Downside Potential
This price target is based on 19 analysts offering 12 month price targets for HCA Healthcare in the last 3 months. The average price target is $240.44, with a high forecast of $290.00 and a low forecast of $155.00. The average price target represents a -3.23% upside from the last price of $248.46.

This chart shows the closing price for HCA for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 19 polled investment analysts is to buy stock in HCA Healthcare. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 14 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 14 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 15 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 17 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 16 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 15 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 16 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 17 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 17 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/22/2021BarclaysBoost Price TargetOverweight$225.00 ➝ $275.00Low
7/21/2021TruistBoost Price TargetBuy$260.00 ➝ $290.00Medium
7/21/2021Credit Suisse GroupBoost Price TargetOutperform$222.00 ➝ $267.00Low
7/21/2021MizuhoBoost Price TargetBuy$232.00 ➝ $275.00Low
7/21/2021Raymond JamesBoost Price TargetOutperform$225.00 ➝ $290.00Low
7/21/2021Royal Bank of CanadaBoost Price TargetOutperform$247.00 ➝ $273.00Low
7/21/2021OppenheimerBoost Price TargetOutperform$230.00 ➝ $275.00Low
7/21/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$225.00 ➝ $275.00Low
7/21/2021BMO Capital MarketsBoost Price TargetMarket Perform$235.00 ➝ $250.00Low
7/21/2021CitigroupBoost Price TargetNeutral$215.00 ➝ $268.00Low
7/19/2021The Goldman Sachs GroupBoost Price TargetBuy$223.00 ➝ $252.00Low
7/9/2021Seaport Res PtnReiterated RatingBuyLow
7/9/2021Seaport Global SecuritiesInitiated CoverageNeutral ➝ Buy$235.00Medium
6/18/2021Jefferies Financial GroupReiterated RatingBuyHigh
4/29/2021Raymond JamesReiterated RatingOutperform$190.00 ➝ $225.00Medium
4/29/2021Royal Bank of CanadaBoost Price TargetOutperform$205.00 ➝ $232.00N/A
4/29/2021MizuhoBoost Price TargetBuy$205.00 ➝ $232.00N/A
4/26/2021CitigroupDowngradeBuy ➝ NeutralLow
4/26/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$210.00 ➝ $225.00Low
4/26/2021BMO Capital MarketsBoost Price TargetMarket Perform$200.00 ➝ $222.00Low
4/23/2021Raymond JamesBoost Price TargetOutperform$190.00 ➝ $225.00Low
4/23/2021OppenheimerBoost Price TargetOutperform$200.00 ➝ $230.00Low
4/23/2021BarclaysBoost Price TargetOverweight$195.00 ➝ $225.00High
4/23/2021MizuhoBoost Price TargetBuy$205.00 ➝ $232.00High
4/23/2021Royal Bank of CanadaBoost Price TargetOutperform$205.00 ➝ $232.00High
4/19/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$210.00 ➝ $225.00N/A
4/14/2021TruistBoost Price Target$200.00 ➝ $230.00Medium
4/14/2021Truist SecuritiesBoost Price TargetBuy$200.00 ➝ $230.00Low
4/13/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$180.00 ➝ $210.00Medium
4/9/2021MizuhoBoost Price TargetBuy$195.00 ➝ $205.00Medium
2/5/2021MizuhoBoost Price TargetBuy$180.00 ➝ $195.00Medium
2/4/2021UBS GroupBoost Price TargetBuy$164.00 ➝ $203.00High
2/3/2021CitigroupBoost Price Target$185.00 ➝ $191.00Low
2/3/2021Credit Suisse GroupBoost Price TargetOutperform$197.00 ➝ $201.00High
2/3/2021Raymond JamesBoost Price TargetOutperform$150.00 ➝ $190.00High
1/5/2021TruistBoost Price Target$165.00 ➝ $190.00N/A
1/5/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$150.00 ➝ $180.00N/A
12/18/2020MizuhoBoost Price TargetBuy$170.00 ➝ $180.00Low
12/15/2020The Goldman Sachs GroupInitiated CoverageBuy$191.00Medium
12/14/2020JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$143.00 ➝ $194.00High
12/7/2020MizuhoBoost Price TargetBuy$150.00 ➝ $170.00Medium
11/11/2020Piper SandlerBoost Price TargetOverweight$149.00 ➝ $163.00High
10/27/2020Smith Barney CitigroupBoost Price Target$142.00 ➝ $155.00Medium
10/27/2020Piper SandlerBoost Price TargetNeutral$138.00 ➝ $149.00High
10/27/2020Raymond JamesBoost Price TargetOutperform$140.00 ➝ $150.00High
10/27/2020Credit Suisse GroupBoost Price TargetOutperform$158.00 ➝ $164.00High
10/27/2020MizuhoBoost Price TargetBuy$145.00 ➝ $150.00High
10/27/2020BarclaysBoost Price TargetOverweight$140.00 ➝ $150.00High
10/9/2020CSFBBoost Price TargetOutperform$143.00 ➝ $158.00Medium
10/9/2020Credit Suisse GroupBoost Price TargetOutperform$143.00 ➝ $158.00High
9/21/2020JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$161.00 ➝ $143.00High
9/16/2020TruistBoost Price TargetBuy$150.00 ➝ $165.00Low
7/24/2020JPMorgan Chase & Co.Boost Price TargetOverweight$142.00 ➝ $161.00Low
7/23/2020OppenheimerBoost Price Target$135.00 ➝ $140.00High
7/23/2020Deutsche Bank AktiengesellschaftBoost Price Target$132.00 ➝ $150.00Medium
7/23/2020Piper SandlerBoost Price TargetNeutral$132.00 ➝ $138.00Low
7/23/2020Raymond JamesBoost Price TargetCautious ➝ Outperform$130.00 ➝ $140.00High
7/23/2020SunTrust BanksBoost Price TargetBuy$130.00 ➝ $150.00High
7/23/2020MizuhoBoost Price TargetBuy$136.00 ➝ $145.00High
7/23/2020CitigroupBoost Price TargetBuy$131.00 ➝ $142.00High
7/13/2020BMO Capital MarketsDowngradeOutperform ➝ Market Perform$121.00 ➝ $100.00Low
6/11/2020UBS GroupLower Price TargetBuy$138.00 ➝ $137.00High
5/29/2020MizuhoLower Price TargetBuy$150.00 ➝ $136.00High
5/20/2020CitigroupLower Price TargetBuy$168.00 ➝ $131.00Medium
4/27/2020UBS GroupLower Price TargetBuy$183.00 ➝ $138.00Low
4/22/2020SunTrust BanksLower Price TargetBuy$160.00 ➝ $140.00Medium
4/22/2020BarclaysBoost Price TargetOverweight$117.00 ➝ $127.00Medium
4/22/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$165.00 ➝ $132.00Medium
4/22/2020OppenheimerLower Price TargetOutperform$160.00 ➝ $135.00Medium
4/20/2020Raymond JamesLower Price TargetOutperform$165.00 ➝ $130.00High
4/13/2020SunTrust BanksLower Price TargetBuy$185.00 ➝ $160.00High
3/25/2020BarclaysReiterated RatingBuy$117.00High
3/19/2020Credit Suisse GroupReiterated RatingBuy$173.00Low
2/3/2020BarclaysBoost Price TargetOverweight ➝ Positive$172.00 ➝ $177.00Low
1/29/2020SunTrust BanksReiterated RatingBuy$185.00Medium
1/29/2020Robert W. BairdBoost Price TargetOutperform$160.00 ➝ $180.00Low
1/29/2020Credit Suisse GroupBoost Price TargetOutperform$169.00 ➝ $173.00Low
1/29/2020StephensBoost Price TargetOverweight$175.00 ➝ $180.00Medium
1/29/2020CitigroupBoost Price TargetBuy$156.00 ➝ $168.00Medium
1/29/2020Royal Bank of CanadaBoost Price TargetOutperform$170.00 ➝ $173.00Medium
1/27/2020The Goldman Sachs GroupReiterated RatingBuy$165.00High
1/3/2020Deutsche Bank AktiengesellschaftInitiated CoverageBuy$140.00Low
12/20/2019JPMorgan Chase & Co.Boost Price TargetOverweight$157.00 ➝ $186.00Low
12/6/2019Bank of AmericaUpgradeNeutral ➝ BuyHigh
10/30/2019BarclaysBoost Price TargetOverweight$145.00 ➝ $155.00Low
9/6/2019Bank of AmericaUpgradeUnderperform ➝ Neutral$130.00 ➝ $137.00Medium
8/7/2019StephensSet Price TargetBuy$150.00Low
7/31/2019MizuhoSet Price TargetBuy$153.00N/A
7/10/2019The Goldman Sachs GroupUpgradeNeutral ➝ Buy$147.00 ➝ $160.00Low
6/24/2019UBS GroupBoost Price TargetBuy$172.00 ➝ $181.00Medium
5/1/2019UBS GroupBoost Price TargetBuy ➝ Buy$164.00 ➝ $172.00Low
5/1/2019Deutsche Bank AktiengesellschaftBoost Price TargetBuy ➝ Buy$160.00 ➝ $165.00Medium
4/23/2019Raymond JamesUpgradeMarket Perform ➝ Outperform$115.00 ➝ $135.00High
4/17/2019Jefferies Financial GroupSet Price TargetBuy$158.00High
4/17/2019BarclaysLower Price TargetOverweight ➝ Overweight$155.00 ➝ $145.00Low
1/30/2019OppenheimerBoost Price TargetOutperform$142.00 ➝ $150.00Low
1/30/2019SunTrust BanksBoost Price TargetBuy$175.00Low
1/30/2019SVB LeerinkBoost Price TargetOutperform$160.00 ➝ $175.00Low
1/14/2019StephensInitiated CoverageOverweight$143.00Low
1/3/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy ➝ Buy$140.00Medium
11/15/2018UBS GroupInitiated CoverageBuy ➝ Buy$162.00Medium
11/6/2018ArgusBoost Price TargetBuy ➝ Buy$150.00 ➝ $155.00Low
11/1/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$156.00 ➝ $165.00Low
10/31/2018Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$155.00 ➝ $158.00Low
10/11/2018CitigroupBoost Price TargetBuy$136.00 ➝ $156.00Medium
9/21/2018Jefferies Financial GroupBoost Price TargetBuy$155.00Low
9/20/2018Robert W. BairdBoost Price TargetOutperform ➝ Positive$130.00 ➝ $150.00Low
9/18/2018Bank of AmericaBoost Price TargetUnderperform$125.00 ➝ $135.00Medium
9/10/2018Royal Bank of CanadaBoost Price TargetOutperform$150.00Low
9/7/2018ArgusBoost Price TargetBuy$150.00Low
9/5/2018Morgan StanleyBoost Price TargetUnderweight ➝ Underweight$115.00 ➝ $124.00Low
9/5/2018BMO Capital MarketsBoost Price TargetOutperform ➝ Buy$145.00 ➝ $155.00Low
9/4/2018SunTrust BanksBoost Price TargetBuy ➝ Positive$150.00High
9/4/2018SVB LeerinkBoost Price TargetOutperform ➝ Outperform$140.00 ➝ $150.00Low
9/4/2018MizuhoSet Price TargetBuy$150.00Low
8/16/2018Morgan StanleyBoost Price TargetUnderweight ➝ Underweight$105.00 ➝ $115.00Medium
8/14/2018BarclaysInitiated CoverageOverweight$150.00Low
8/2/2018MizuhoReiterated RatingBuy$145.00Low
7/30/2018JPMorgan Chase & Co.Boost Price TargetOverweight$151.00Low
7/27/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$122.00 ➝ $143.00Low
7/26/2018Piper Jaffray CompaniesReiterated RatingHold$124.00Low
7/26/2018Jefferies Financial GroupReiterated RatingBuy$135.00Medium
7/26/2018SunTrust BanksBoost Price TargetBuy$145.00High
7/26/2018SVB LeerinkBoost Price TargetOutperform$125.00 ➝ $140.00High
7/20/2018Cantor FitzgeraldReiterated RatingBuy$115.00Low
7/20/2018SunTrust BanksReiterated RatingBuy$125.00Low
7/13/2018Morgan StanleyBoost Price TargetUnderweight$91.00 ➝ $98.00Low
3/23/2018MizuhoInitiated CoverageBuy$115.00Medium
2/12/2018ArgusBoost Price TargetPositive ➝ Buy$9.26 ➝ $114.00Low
2/1/2018Sanford C. BernsteinReiterated RatingMarket Perform$105.00 ➝ $116.00Low
2/1/2018BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$96.00 ➝ $115.00Low
2/1/2018Morgan StanleyBoost Price TargetUnderweight ➝ Underweight$84.00 ➝ $91.00Low
1/31/2018Royal Bank of CanadaBoost Price TargetOutperform$117.00Low
1/31/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$115.00 ➝ $122.00Low
1/31/2018SVB LeerinkBoost Price TargetOutperform ➝ Outperform$105.00 ➝ $120.00Low
1/31/2018SunTrust BanksBoost Price TargetBuy ➝ Positive$120.00Low
1/30/2018Piper Jaffray CompaniesReiterated RatingHold$101.00Low
1/30/2018Cantor FitzgeraldReiterated RatingBuy$115.00High
1/30/2018Wells Fargo & CompanyInitiated CoverageOutperform ➝ Outperform$116.00High
1/24/2018William BlairReiterated RatingHoldMedium
1/12/2018Robert W. BairdSet Price TargetBuy$104.00Medium
1/10/2018ArgusSet Price TargetBuy$97.00Low
1/4/2018Bank of AmericaDowngradeNeutral ➝ Underperform$94.00 ➝ $90.00Medium
1/3/2018The Goldman Sachs GroupInitiated CoverageNeutral ➝ NeutralHigh
1/3/2018Piper Jaffray CompaniesDowngradeOverweight ➝ Neutral$81.00High
12/26/2017Credit Suisse GroupReiterated RatingOutperform$25.00Low
12/21/2017SunTrust BanksSet Price TargetBuy$105.00Low
12/20/2017Morgan StanleyDowngradeEqual Weight ➝ Underweight$85.00High
12/12/2017CitigroupUpgradeNeutral ➝ BuyMedium
11/30/2017JPMorgan Chase & Co.UpgradeNeutral ➝ OverweightHigh
11/21/2017William BlairReiterated RatingMarket PerformN/A
11/6/2017CitigroupLower Price TargetNeutral ➝ Neutral$87.00 ➝ $81.00N/A
11/2/2017Credit Suisse GroupInitiated CoverageOutperform$95.00N/A
11/1/2017Jefferies Financial GroupLower Price TargetBuy$90.00 ➝ $88.00N/A
11/1/2017MizuhoLower Price TargetBuy$85.00 ➝ $84.00N/A
11/1/2017Piper Jaffray CompaniesReiterated RatingBuy$82.00N/A
10/31/2017Cantor FitzgeraldReiterated RatingBuy$90.00N/A
10/20/2017MizuhoReiterated RatingBuyN/A
10/19/2017Robert W. BairdSet Price TargetBuy$93.00 ➝ $86.00N/A
10/19/2017OppenheimerReiterated RatingBuy$95.00 ➝ $90.00N/A
10/19/2017Bank of AmericaLower Price TargetNeutral$92.00 ➝ $86.00N/A
10/19/2017Royal Bank of CanadaReiterated RatingOutperform$90.00N/A
10/19/2017KeyCorpReiterated RatingOverweight$95.00 ➝ $90.00N/A
10/19/2017Jefferies Financial GroupReiterated RatingBuy$90.00N/A
10/18/2017Raymond JamesDowngradeStrong-Buy ➝ Market PerformN/A
10/18/2017UBS GroupDowngradeOutperform ➝ Market PerformN/A
10/16/2017BMO Capital MarketsInitiated CoverageOutperform$90.00N/A
10/15/2017SunTrust BanksSet Price TargetBuy$90.00N/A
10/13/2017Cantor FitzgeraldReiterated RatingBuy$95.00N/A
10/13/2017Jefferies Financial GroupReiterated RatingBuy$92.00N/A
10/4/2017MizuhoReiterated RatingBuy$92.00N/A
10/4/2017Piper Jaffray CompaniesReiterated RatingBuy$92.00High
9/28/2017Robert W. BairdReiterated RatingBuyLow
9/7/2017KeyCorpReiterated RatingBuy$95.00Low
9/6/2017Cantor FitzgeraldReiterated RatingBuy$95.00Low
8/22/2017Robert W. BairdLower Price TargetOutperform$95.00 ➝ $93.00Low
8/17/2017Morgan StanleyLower Price TargetEqual Weight$88.00 ➝ $85.00Low
8/14/2017ArgusLower Price TargetBuy$100.00 ➝ $93.00Low
7/26/2017CitigroupLower Price TargetNeutral$89.00 ➝ $87.00Medium
7/26/2017Morgan StanleyReiterated RatingEqual Weight$90.00 ➝ $88.00Low
7/26/2017Bank of AmericaDowngradeBuy ➝ Neutral$102.00 ➝ $92.00Medium
6/28/2017ArgusInitiated CoverageBuy ➝ Buy$100.00Low
6/6/2017SVB LeerinkUpgradeMarket Perform ➝ Outperform$92.00 ➝ $100.00Low
6/6/2017Morgan StanleyInitiated CoverageEqual ➝ Equal Weight$90.00Low
4/17/2017Cantor FitzgeraldReiterated RatingBuy$95.00High
4/4/2017Deutsche Bank AktiengesellschaftInitiated CoverageBuy$103.00Low
3/27/2017MizuhoUpgradeNeutral ➝ Buy$98.00High
2/1/2017Royal Bank of CanadaReiterated RatingOutperform$95.00 ➝ $98.00N/A
2/1/2017Royal Bank of CanadaBoost Price TargetOutperform$95.00 ➝ $98.00N/A
1/31/2017Evercore ISIBoost Price TargetBuy$88.00N/A
1/17/2017Avondale PartnersUpgradeMarket Perform ➝ Outperform$96.00N/A
1/4/2017Piper Jaffray CompaniesInitiated CoverageOverweight$81.00N/A
11/15/2016Sanford C. BernsteinReiterated RatingMarket Perform$89.00 ➝ $85.00N/A
11/9/2016Avondale PartnersDowngradeOutperform ➝ Market PerformN/A
11/9/2016MizuhoDowngradeBuy ➝ NeutralN/A
10/28/2016Royal Bank of CanadaReiterated RatingOutperform$88.00 ➝ $95.00N/A
10/28/2016Royal Bank of CanadaBoost Price TargetOutperform$88.00 ➝ $95.00N/A
10/25/2016Wolfe ResearchInitiated CoverageOutperformN/A
10/13/2016KeyCorpUpgradeSector Weight ➝ Overweight$94.00N/A
9/22/2016Evercore ISIInitiated CoverageHold$89.00N/A
9/6/2016Jefferies Financial GroupReiterated RatingBuyN/A
8/26/2016Jefferies Financial GroupReiterated RatingBuy$94.00N/A
8/10/2016Jefferies Financial GroupReiterated RatingBuyN/A
7/29/2016Credit Suisse GroupReiterated RatingBuy$87.00N/A
7/29/2016CitigroupLower Price TargetNeutral$86.00 ➝ $85.00N/A
7/29/2016MizuhoReiterated RatingBuy$102.00 ➝ $97.00N/A
7/29/2016JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$85.00N/A
(Data available from 7/25/2016 forward)
HCA Healthcare logo
HCA Healthcare, Inc., through its subsidiaries, operates as a health care services company in the United States. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, and adolescent and adult alcohol and drug abuse treatment and counseling. In addition, the company operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. As of December 31, 2020, it operated 185 hospitals, which included 178 general, acute care hospitals, as well as five psychiatric hospitals and two rehabilitation hospitals; 121 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Read More

Today's Range

Now: $248.46
Low: $246.35
High: $250.34

50 Day Range

MA: $214.21
Low: $201.36
High: $249.25

52 Week Range

Now: $248.46
Low: $114.38
High: $254.45


1,484,560 shs

Average Volume

1,426,039 shs

Market Capitalization

$82.15 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of HCA Healthcare?

The following sell-side analysts have issued research reports on HCA Healthcare in the last year: Barclays PLC, BMO Capital Markets, Citigroup Inc., Credit Suisse Group AG, CSFB, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group Inc., JPMorgan Chase & Co., Mizuho, Oppenheimer Holdings Inc., Piper Sandler, Raymond James, Royal Bank of Canada, Seaport Global Securities, Seaport Res Ptn, Smith Barney Citigroup, The Goldman Sachs Group, Inc., TheStreet, Truist, Truist Securities, UBS Group AG, and Zacks Investment Research.
View the latest analyst ratings for HCA.

What is the current price target for HCA Healthcare?

18 Wall Street analysts have set twelve-month price targets for HCA Healthcare in the last year. Their average twelve-month price target is $240.44, suggesting a possible downside of 3.2%. Raymond James has the highest price target set, predicting HCA will reach $290.00 in the next twelve months. Smith Barney Citigroup has the lowest price target set, forecasting a price of $155.00 for HCA Healthcare in the next year.
View the latest price targets for HCA.

What is the current consensus analyst rating for HCA Healthcare?

HCA Healthcare currently has 2 hold ratings and 17 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe HCA will outperform the market and that investors should add to their positions of HCA Healthcare.
View the latest ratings for HCA.

What other companies compete with HCA Healthcare?

How do I contact HCA Healthcare's investor relations team?

HCA Healthcare's physical mailing address is ONE PARK PLAZA, NASHVILLE TN, 37203. The company's listed phone number is 615-344-9551 and its investor relations email address is [email protected] The official website for HCA Healthcare is www.hcahealthcare.com.